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ABSTRACT: Simultaneous electrochemical and electrophysiolog-
ical data were recorded to evaluate the effects of controlled local
application of dopaminergic agonists and antagonists in awake rats.
Measurements were made with a probe consisting of a carbon-fiber
microelectrode fused to three iontophoretic barrels used to
introduce the drugs of interest. The probe and the manipulator
used to position it in the brain of behaving animals were optimized
to improve their performance. The effect of the dopamine
autoreceptor on electrically stimulated release was demonstrated.
Dopamine inhibited the release of endogenous dopamine whereas raclopride, a D2 antagonist, enhanced it, with similar
responses in anesthetized and awake animals. We also examined changes in the firing rate of nucleus accumbens (NAc) neurons
in awake animals during and after brief (15 s) iontophoretic ejections of SCH 23390 (D1 receptor antagonist) or raclopride.
Changes in response to these antagonists were seen both immediately and on a prolonged time scale. Application of raclopride
increased the firing rate in 40% of medium spiny neurons (MSNs), of which half responded immediately. Decreases in firing rate
were observed in 46% of MSNs after SCH 23390 application. Only 11% of MSNs responded to both antagonists and one MSN
(3%) showed no response to either drug. The same prolonged response in firing rate was seen for electrically stimulated and
locally applied dopamine in 75% of MSNs. These results are in agreement with previously reported distributions for dopamine
receptor subtypes on MSNs and probe the effects of dopamine on these cell populations.
KEYWORDS: Iontophoresis, fast-scan cyclic voltammetry, electrophysiology, dopamine receptors, nucleus accumbens,
medium spiny neuron
The modulation of target neurons via neurotransmitterrelease is central to the regulation of an organism’s
behavior. Dopamine plays an extensive role in governing
motivated behaviors and our groups have shown that its release
coincides with learned associations for rewarding stimuli and
drugs of abuse.1−5 Here, we describe a technique that is capable
of monitoring extracellular dopamine release and postsynaptic
cell activity in awake, behaving animals. At a single carbon-fiber
electrode of micrometer dimensions, dopamine release is
detected by fast-scan cyclic voltammetry and postsynaptic cell
activity is monitored by single-unit recordings. The electrode is
coupled to micropipets that with the application of current
locally deliver pharmacological agents to investigate the specific
receptor(s) activated. This approach was first developed by
Millar and co-workers who used fast-scan cyclic voltammetry
and single-unit recording at a single carbon-fiber electrode.6
They combined these techniques with iontophoresis to
compare the response of striatal medium spiny neurons
(MSNs) to locally applied dopamine and endogenous
dopamine released by electrical stimulation.7 Despite the utility
of this approach, it has been used only rarely in behaving
animals.8,9 Here we evaluate this approach in awake animals to
probe the effects of dopamine in the nucleus accumbens
(NAc), a striatal subregion involved in reward processing, on
evoked dopamine release and the electrical activity of MSNs.
Establishing the nature of dopamine responses proved
difficult in early studies using iontophoresis combined with
single-unit recording for several reasons.10 First, many of those
recordings were in anesthetized animals and anesthesia is
known to alter neuronal activity.11,12 Second, the amount of
drug delivered by iontophoresis was not quantifiable. Too little
drug delivered results in a false negative whereas too much
leads to nonspecific effects. Applied pump currents were
commonly used to compare ejections,13−15 but the same pump
current ejected different drug concentrations from barrel to
barrel.16 To remedy this, we monitor the iontophoretic
coejection of an electroactive molecule with the drug of
interest from the same barrel. When the relative mobilities of
the coejected substances are known, monitoring the concen-
tration of the electroactive molecule with the carbon-fiber
electrode provides an indirect measure of the relative
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concentration of the coejected nonelectroactive substance.17,18
Third, ionic and electrical artifacts can occur in iontophoresis.
Since the chemical and physiological environments are
monitored with the combined voltammetry/single-unit record-
ing probe, these problems become apparent during the
experiment and can be corrected. Finally, many studies were
completed before the recognition of various subtypes of
dopamine receptors and before investigators realized that
dopamine receptors are coupled to second messenger systems
that modulate the effects of classical neurotransmitters such as
glutamate. In addition, MSNs have “up” and “down” states
during which the cell’s response to dopamine may differ and are
not discernible with single-unit recordings.19−21
Interpretation of dopamine responses in prior studies were
further complicated by the lack of understanding of the
distribution of dopamine receptors. Dopamine neurons in the
NAc synapse onto dendrites and spines of MSNs.22 MSNs are
GABAergic and comprise 95% of the cell bodies in this
region.23 Glutamatergic neurons that project from the cortex
also form synapses on MSNs. Recent anatomical discoveries
have shown that the predominant dopamine receptors, the D1
and D2 receptors, are segregated between two different MSN
populations.24,25 Early studies that focused exclusively on the
dorsal striatum showed that some MSNs project axons to the
output nuclei of the basal ganglia (substantia nigra and internal
capsule of the globus pallidus [GPi]) and are termed the “direct
pathway”. Other MSNs project to the external capsule of the
globus pallidus (GPe) and are termed the “indirect pathway”
because they synapse with neurons that also project back to the
output nuclei. Although this circuitry was originally charac-
terized in the dorsal striatum, it is also found in the NAc.26 In
the NAc core, 53% of MSNs comprise the direct pathway and
have D1 receptors exclusively. Further, 41% of neurons in the
NAc core comprise the indirect pathway and have D2 receptors
exclusively. Thus, an estimated 6% of MSNs in the NAc have
both D1 and D2 receptors.
In this work, we describe the modifications made to the
voltammetry/single-unit recording/iontophoresis probes for
use in awake animals. These improvements enable examination
of the distribution of dopamine receptor subtypes present on
MSNs in the NAc. In addition, we have examined the
immediate and prolonged cell firing effects of endogenous
and exogenous dopamine and dopamine antagonists on the
different types of MSNs. Our initial results agree with
previously reported distributions of dopamine receptors on
MSNs,26 lending credence to our combined technique and
supporting previous in vitro and indirect in vivo studies.
■ RESULTS AND DISCUSSION
Voltammetry/Single-Unit/Iontophoresis Measure-
ments. A diagram of the circuitry associated with these
experiments is shown in Figure 1.27 In this work, the cyclic
voltammograms were collected at 5 Hz (once every 200 ms).
With the scan rate employed (400 V/s), a single cyclic
voltammogram is recorded in 8.5 ms. The total time with the
current transducer connected (20 ms) includes 5.75 ms before
Figure 1. Diagram of the electronics and outputs for combined fast-scan cyclic voltammetry/electrophysiology. The same carbon-fiber electrode and
reference electrode were used for both circuits and the reference electrode also served as ground for the iontophoresis circuit. The output of the
carbon-fiber electrode was connected to a voltage follower to monitor cell firing (upper circuitry). Every 200 ms, the carbon-fiber microelectrode was
switched from the electrophysiology circuit to the lower voltammetry circuitry for 20 ms. In this position, the amplifier controlled the electrode
potential and the current was monitored. The synchronized outputs for both circuits are shown to the right of the circuitry. When the lower circuit
was completed, the electrode was held at −0.4 V then over 8.5 ms scanned from to +1.3 V and back to −0.4 V. The changes in current during each
scan are indicated with arrows. During this time, there were no voltage changes seen in the electrophysiology (when circuit was open but program
still recorded data). With the upper circuit connected, changes in voltage were monitored. The colored marks above the voltage read out indicate
regions of the 180 ms that have been expanded above. Orange spikes are firing of the MSN of interest; purple spikes are firing that looks similar to
the MSN of interest but are not included due to the horizontal portion at the start of the spike. The gray spike is an example of an excluded event.
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the triangular wave to allow for dopamine adsorption and 5.75
ms after the triangular wave to allow the amplifiers to settle. For
the remaining 180 ms between scans, the amplifier connected
to the carbon-fiber electrode is switched (in <1 μs) from a
current transducer to a voltage follower to allow recording of
unit activity. Iontophoresis occurs continuously during the
switching between voltammetry and single-unit recordings via a
separate circuit. The data from each measurement type is
collected on separate computers along with time stamps
allowing synchronization of the data to iontophoretic ejections
or other events.
In prior work, we used continuous iontophoresis over
multiple minutes to affect cell firing frequency.9 Shorter
applications are advantageous because they restrict the drug
to the local environment in which chemical changes and single-
unit activity are measured. Here, we adopted two methods to
monitor ejection effects. With the first method, we measured
changes in cell firing or changes in electrically stimulated
dopamine release shortly after a 15 s iontophoretic ejection.
This approach has the advantage that the electrochemical signal
arising from the ejected internal standard does not interfere
with endogenous chemical measurements. With the second
method we measured changes in cell firing during the 15 s
ejections. This method was primarily used with electro-
physiological recordings.
Electrode Fabrication. We have made several improve-
ments to the construction of iontophoresis probes from the
methods we previously described.17 First, we addressed the
electrical coupling that sometimes occurred between the
iontophoresis barrels and voltammetric barrel due to the
inherent variability in the thickness of the glass pipettes. When
the thickness of the glass between the adjacent barrels is thin or
there are microfractures in the capillaries, electrical coupling
between the iontophoresis barrels is likely to occur. Second, we
improved the quality of the glass seal against the carbon fiber to
help prevent large background currents during voltammetric
recordings. Finally, we modified a commercially available
manipulator to facilitate use of the probes in awake animals.
Reduced electrical coupling and improvements to the carbon
fiber-glass seal were accomplished using a modified fabrication
technique. First, a carbon fiber was inserted into in a single glass
capillary, and this assembly was inserted into one barrel of a
four-barrel prefused glass assembly (Figure 2A). Heat-shrink
tubing was applied to the ends of each multibarrel glass
capillary at the location where the chuck of the pipet puller was
tightened onto the glass. Tack was placed at the lower end to
prevent the inner glass capillary containing the carbon fiber
from falling out. The assembly was pulled on a vertical
micropipet puller in a two-step process that created two
electrodes of the type shown in Figure 2B. The first pull
elongated and narrowed the glass while the second pull formed
the glass seal around the carbon fiber. The carbon fiber was
then trimmed to have an exposed length of 50−75 μm. Before
use, the heat-shrink was removed and an electrical connection
to the carbon fiber was made with silver epoxy and an inserted
silver wire. These procedures minimized the electrical coupling
Figure 2. Modifications to probe construction and hardware for iontophoresis in freely moving animals. (A) Four-barrel prefused pipet ready for
pulling with heat shrink on either end where the glass will contact the chucks of the puller. A smaller capillary containing a T-650 carbon fiber is
loaded into one barrel. (B) One of the two electrodes created from the two-pull electrode making technique. The vertical bar indicates the midpoint
of the pipet before pulling. (C) Environmental scanning electron micrograph of the probe tip showing the glass iontophoresis barrels and carbon
fiber. (D) Hardware used to attach and lower iontophoresis probe into the head of a freely moving animal. (i) Commercially available Biela
manipulator from Crist Instrument Co. (Part# 3-MMB-3D). (ii) Custom machined adapter that allows use of Biela manipulator with a guide cannula
from Bioanalytical Systems, Inc. fabricated by UNC Physics Machine Shop (Chapel Hill, NC). (iii) Commercially available guide cannula from
Bioanalytical Systems.
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between the electrode and the iontophoresis barrels and
resulted in improved carbon-glass seals.
To facilitate use of the voltammetry/single-unit/iontopho-
resis probe in awake animals and allow for lowering to a precise
depth within the brain, the probe was inserted into a
commercially available Biela micromanipulator.28 The manip-
ulator contains a metal tube (Figure 2Di) that has four inner
grooves to hold a four-barrel pipet. This innermost piece moves
up and down as the two outermost parts screw together. The
Biela manipulators are designed for connection to the skull with
a threaded guide cannula that requires a large diameter (1.5
mm) skull opening. The large hole tends to become blocked
with blood clots, which increases the likelihood of pipet
breakage. This problem is less frequent with the guide cannula
that we use with single-barrel electrodes, which requires a 0.65
mm diameter hole (Figure 2Diii). This guide cannula uses a
washer and groove system to attach the micromanipulator to
the skull. The polyamide plastic cannula (2 mm long)
extending beyond the hub was inserted in a hole drilled in
the animal’s brain and permanently affixed with dental cement
during surgery. To mate the manipulator with the smaller
diameter guide cannula, a custom-machined adapter was
fabricated with threads to attach the adapter to the manipulator
(UNC Physics Machine Shop, Chapel Hill, NC). The metal
ridge of the adapter (Figure 2Dii) mates with the groove in the
guide cannula and the washer on the cannula locks the pieces
together. This allows for easy attachment on the animal’s head
under brief isofluorane anesthesia.
Modulation of Dopamine Evoked Release by Autor-
eceptors. Because stimulated release is modulated by D2
autoreceptors,29,30 we used the improved probes to examine
modulation of electrically stimulated (24 pulses, 60 Hz, 125 μA,
repeated at 1 min intervals) dopamine release by agents active
at D2 receptors in anesthetized animals. We first used
microejections of dopamine (16 ± 1 μM) in an attempt to
activate the D2 autoreceptor, but there was no effect on
electrically stimulated release (N = 4 animals) with three
ejections carried out 5−7 min apart. We then continuously
delivered nomifensine (54 ± 2 μM), a dopamine transporter
uptake inhibitor, while continuing stimulations at 1 min
intervals. Under these conditions, the amplitude of electrically
stimulated dopamine release was inhibited 23 ± 6% (p < 0.05,
paired t test) by dopamine. This experiment is summarized in
Figure 3. A lower concentration of dopamine (1.7 ± 0.5 μM)
was also tested in three of the animals and showed the same
inhibition of electrically stimulated dopamine release only
during nomifensine application. By inhibiting uptake, nomi-
fensine allowed dopamine to diffuse greater distances and
remain in the extracellular space longer.31,32 Additionally,
continuous inhibition of the transporter may alter autoreceptor
function.33
We also iontophoresed the D2 receptor antagonist raclopride
in these same locations to ensure [DA]max responded as we
previously showed to autoreceptor antagonism.18 The 15 s
ejection consisted of 21 ± 11 μM raclopride and terminated 10
s before the stimulation. Ejections were repeated three times
7−10 min apart during which electrical stimulation occurred
every 60 s. [DA]max was significantly increased by 151 ± 13%
(N = 4 animals, p < 0.05, paired t test). Even 70 s after the
ejection, [DA]max was still increased by 132 ± 8% but returned
to preraclopride levels 5 min after the conclusion of the
raclopride ejection.
Figure 3. Effect of dopamine transporter on exogenous dopamine
diffusion. (A) Two-dimensional color plot where current is shown in
false color on the potential vs time axes for current changes in the
nucleus accumbens (NAc). The positive (green) currents are
indicative of dopamine release. Anesthetized rats received a 24 pulse,
125 μA, 60 Hz electrical stimulation every 60 s, and maximum
dopamine concentration ([DA]max) evoked with each stimulation
recorded. Stimulations are indicated by red bars below the color plot.
(B) In the same animal, the same experiment was carried out as in (A)
but 54 ± 2 μM nomifensine (NOM) was constantly iontophoresed
during the stimulations. (C) Dopamine (DA) oxidation currents as a
function of time. Traces were taken from the potentials marked with
dashed lines in panels (A) and (B). (D) 15 s ejection of 16 ± 1 μM
dopamine occurred at the vertical blue line and ended 10 s before
electrical stimulation at t = 0 s. Open triangles indicate dopamine
ejections, while black triangles indicate dopamine ejections made
during constant application of nomifensine. [DA]max evoked was
greater in the presence of nomifensine, but all data is presented as
percent of pre-ejection [DA]max for each data set.
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We also looked at the effect of autoreceptor antagonism on
the amplitude of stimulated dopamine release in the NAc of
awake, behaving animals. Awake animals were trained to press a
lever that delivered an electrical stimulation to the ventral
tegmental area (VTA). Rats quickly learn this behavior termed
intracranial self-stimulation (ICSS) that was discovered almost
60 years ago.34 To ensure dopamine release was not depleted
by rapid lever pressing,35 a variable time out (VTO) paradigm,
with lever availability 18−27 s after a previous lever press was
used. This VTO allowed for a 15 s drug ejection between
presses as well. Data logging of [DA]max was initiated when it
had reached a stable value.36 After multiple lever-pressing trials,
raclopride was ejected for 15 s and was terminated 3 s before
the next lever extension. This caused an immediate increase in
the maximum concentration of evoked dopamine that was
observed after each lever press (Figure 4). This increase
occurred at all locations tested, with raclopride increasing
[DA]max at each location to 280 ± 130% the preraclopride
[DA]max (N = 10 animals). This broad range of responses to
raclopride is likely due to the variability in the distance between
the probe tip (and the fixed distance between the carbon fiber
and point where drug is introduced into the system) and
affected receptors. This approach is an important improvement
over systemic injections of dopamine receptor antagonists
which can alter behavior and confound investigation of receptor
mechanisms; localized iontophoretic application of raclopride
allows modulation of receptors without affecting an animal’s
behavior.37
Modulation of Cell Firing with D1 and D2 Receptor
Antagonists. We did not attempt measurements of MSN unit
activity in anesthetized animals because firing rates are so low
under these conditions that investigators typically need to use
glutamate to increase activity.11,38,39 In the awake rat, we
examined the effects of the D1 antagonist, SCH 23390, the D2
antagonist, raclopride, and dopamine on MSN firing rate
(dopamine results are described later). Representative histo-
grams for responses to iontophoretic drug applications are
shown in Figure 5, all measured at the same cell. Figure 5A
shows a sample MSN waveform, shape of the waveform
remained constant for all test conditions. In these experiments
the same concentration of drug was applied to the cell for 15 s
once every 60 s. The histograms are the average firing rate
centered around these 30 drug applications with cell firing
placed in 1.0 s bins. Drug was introduced for 15 s starting at t =
0 s, and the average firing rate for 15 s before and after drug
delivery also shown. The blue trace superimposed on each
histogram is the average concentration of drug ejected over the
time the histograms were collected. Figure 5B shows the
average firing rate for the MSN over 30 trials during which no
drug ejections occurred. This served to ensure that the cell was
firing at a constant rate over a 30 min period.
To evaluate the immediate effect of iontophoretic drug
application on MSN firing rates, we compared firing ratios. The
firing ratio allows comparison of cell firing changes with respect
to a defined baseline period. Here, baseline was defined as the
average firing rate during the 15 s interval prior to each
iontophoretic application (red bars in Figure 5). The firing ratio
was determined by dividing the average firing rate during 30
consecutive drug ejections (the region shown by the blue open
bars in Figure 5) by the baseline. The drug was deemed to have
an immediate effect if it caused a change in firing ratio of 50%
or more, a change never observed without drug application. At
the location of the trials in Figure 5, the cell showed no
immediate change in firing in response to application of 8.6 μM
SCH 23390 (Figure 5C) whereas there was an abrupt increase
in firing rate (and firing ratio) with the application of 14 μM
raclopride (Figure 5D). This increase in cell firing is believed to
be an excitation in response to blocking of the D2 mediated
inhibition of MSN firing. The results from multiple units are
summarized in Table 1 and show that only 12 out of the 30
cells that responded to one dopamine antagonist showed an
immediate response.
The time required for a change in cell firing to occur is
dependent on the time needed for ejected drug to diffuse to
receptors on the MSN as well as the time delay between
binding and the cascade of cell signaling that modulates MSN
firing. Therefore, we also analyzed the data over a prolonged
time scale. For prolonged firing ratios, baseline was taken as the
average MSN firing rate during 30 trials with no drug ejections
(red bar in Figure 6A). The prolonged firing ratio was then the
average firing rate in the 15 s before and the 15 s after each of
the 30 drug ejections (Figure 6B−E) divided the prolonged
baseline. (The prolonged firing ratio purposely excludes cell
firing during the 15 s period of drug ejection, which was used
for determination of the immediate firing ratio.) Note that the
−15 to 0 s period before an ejection was also the time period
45−60 s after an ejection after the first ejection.
Representative firing patterns of another single unit are
shown in Figure 6 along with the time periods used to calculate
the prolonged firing ratio. Figure 6A shows the baseline for the
prolonged measure (no drug was ejected), Figure 6B shows
trials where SCH 23390 was ejected, and Figure 6C shows trials
where raclopride was ejected. The immediate and prolonged
firing ratios for each condition at this location are seen in
Figure 4. Consistent modulation of electrically evoked dopamine release with raclopride antagonism of the presynaptic D2 receptor during ICSS in a
behaving rat. Stimulated release of dopamine occurred each time the animal pressed a lever, and the maximum amplitude was recorded as the
maximum dopamine concentration ([DA]max). The lever was made available to the animal once every 18−27 s. Raclopride iontophoretic ejections
(15 s, 100 nM) began at 13 min. The ejections terminated 3 s before the lever became available (indicated by vertical lines).
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Figure 6F. At this cell, SCH 23390 had a prolonged inhibition
on cell firing but no immediate effect (Figure 6B, F).
Raclopride had no significant effect on the firing ratio on
either time scale in this MSN (Figure 6C, F). These responses
classify this cell as a D1 responsive MSN.
This analysis was repeated for 35 cells, and the results are
also summarized as the prolonged changes in Table 1. Out of
35 cells, all but one showed a prolonged response to receptor
antagonists. While 4 units showed a prolonged response to
both antagonists, 16 were only responsive to the D1 antagonist
and 14 were only responsive to the D2 antagonist. This
breakdown of cells is remarkably similar to the ratio of D1 and
D2 cells established in the NAc by Girault and co-workers.24
The 5 prolonged inhibitions evoked by raclopride all exhibited
a robust, immediate excitation (like the example in Figure 5).
The variability of the prolonged responses in MSNs that just
responded to raclopride (5 out of 18 cells were inhibited while
the remainder were excited) may have to do with the dual
locations of D2 receptors.40−42 Activation of D2 receptors on
MSNs tends to inhibit cell firing whereas activation of D2
autoreceptors on dopamine neurons decreases dopamine
release, minimizing this inhibition.
Modulation of Cell Firing with Dopamine. At the same
locations where the effects of raclopride and SCH 23390 were
evaluated, we also evaluated the changes in firing rate induced
by iontophoretically delivered dopamine and dopamine
released by electrical stimulation (examples shown in Figure
6D and E). Iontophoresis of dopamine over a range of
concentrations (10 nM to 20 μM) into the NAc caused no
immediate change in MSN unit activity in 36 of the 40 cells
tested (representative example in Figure 5E). However, only
18% of MSNs were unresponsive to either mode of dopamine
delivery like the MSN in Figure 6. This means 82% of MSN
showed a prolonged response to dopamine. In Table 2, the cells
are grouped according to their prolonged responses to
dopamine evoked by electrical stimulation or iontophoresis.
Here, 75% of the MSNs monitored show the same type of
prolonged response to both locally applied dopamine and
electrical stimulation. Our result contrasts with that of Millar
and co-workers who found electrically stimulated dopamine
could excite or inhibit cell firing, but iontophoresed dopamine
never excited cell firing.7 Our results also contrast with those of
Gonon who found that transient electrical stimulations caused
D1-mediated excitation of MSNs.43 However, both of the prior
reports were in anesthetized preparations. The changes in firing
rate induced by increased extracellular dopamine concentration
Figure 5. Immediate response of a single NAc MSN to iontophoretic
application of dopamine receptor antagonists, SCH 23390 and
raclopride, and dopamine in an awake animal. (A) Sample waveforms
(150) shown in black with the average of the waveforms in gray for a
NAc MSN collected in these experiments. The horizontal scale bar
represents 0.3 ms, and vertical scale bar is 300 μV. (B) MSN firing
with no iontophoretic ejections. (C) MSN firing during iontophoresis
of 23 nM SCH 23390 for 15 s starting at t = 0 s. (D) MSN firing with
40 nM raclopride iontophoresed for 15 s starting at t = 0 s. (E) MSN
firing with 12 μM of dopamine iontophoresed for 15 s starting at t = 0
s. Histograms are the average of 30 consecutive trials (60 s duration)
and each bar is the average frequency recorded during the indicated 1 s
bin. All histograms were collected in the same location in the NAc of
the same animal. The blue traces superimposed over histograms are
the average concentration of acetaminophen (AP) (C, D) or
dopamine (DA) (E) ejected during the 45 s window shown for all
30 trials. In panels (C)−(E), iontophoretic drug delivery started at t =
0 s and ended at t = 15 s. Immediate changes in firing ratio were
determined by comparison of cell firing during a baseline period (−15
to 0 s, solid red bar) to the average firing rate during the ejection (blue
boxed region, 0 to 15 s). A quotient that differed from the control by
±0.5 was taken as an immediate change in cell firing rate.
Table 1. Distribution of Prolonged and Immediate
Responses of MSNs to Dopamine Antagonistsa
no. of cells (%)
type of response raclopride SCH 23390
immediate
inhibitory 0 (0) 1 (3)
excitatory 7 (23) 4 (13)
prolonged
inhibitory 5 (17) 16 (53)
excitatory 9 (30) 0 (0)
aMSN = medium spiny neuron. MSN responses are tabulated from n
= 35 cells (units) from 19 rats. One cell did not respond to either drug,
and 4 cells responded to both. All 5 of these cells were excluded from
the table.
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show that MSN firing rates can be modulated even in the
absence of a coordinated surge of glutamate or GABA. For the
25% of the cells in which dopamine and the electrical
stimulation do not cause the same firing rate changes, it may
be that the stimulation releases other neurotransmitters besides
dopamine that contribute to the observed effect. For example,
GABA44,45 and glutamate46 are released in conjunction with
dopamine at some percentage of NAc synapses.
■ CONCLUSIONS
Here we characterized an improved procedure to combine
iontophoresis with voltammetric/single-unit recording that
eliminates much of the unpredictability seen in earlier
applications of this technique. We have established that drug
ejections 15 s in duration can alter both chemical release and
cell firing on different time scales. Previous experiments with
iontophoresis showed that long ejections of SCH 23390
inhibited cell firing.9 In agreement with this, here we found a
population of MSNs that showed prolonged inhibition
following exposure to SCH 23390. MSNs that showed a
prolonged response to raclopride were more variable with only
40% of MSNs having a significant increase in firing rate. These
changes in firing rate were induced by only 15 s of drug
application (vs several minutes). In agreement with prior work
in anesthetized animals, we find that dopamine may either
increase or decrease firing rate at different MSNs.39
The results with raclopride on pre- and postsynaptic events
differ in their onset time. Raclopride modulates dopamine
release immediately and robustly after its application (Figure
3), but tends to be more effective in the prolonged modulation
of MSN firing rate. These effects are mediated by two different
isoforms of the D2 receptor that are found pre- and
postsynaptically.47 Because of the high density of dopaminergic
terminals, the presynaptic effects on dopamine release are
readily observed by iontophoresis in the NAc. By contrast,
spikes from MSN cell bodies are encountered less frequently.
Because their dendrites extend several hundred micrometers
away,48 this may explain why prolonged effects of dopamine
antagonists were obtained more reliably than immediate effects.
While both pre- and postsynaptic D2 receptors exhibit similar
pharmacology,49 they differ in that the postsynaptic D2
receptor has a longer third intracellular loop that requires the
presence of Gαi2 in order to inhibit adenylyl cyclase to the same
extent that the presynaptic D2 receptor can with any Gαi
protein.50,51 Functionally, this means more binding may be
Figure 6. Firing rates measured at another MSN indicating the
prolonged analysis method. Each histogram was constructed from the
results of 30 trials for each condition, (A) Control where no event
occurs (B) 15 s SCH 23390 (SCH) ejection, indicated by back bar (C)
15 s raclopride (RAC) ejection, indicated by back bar (D) 15s
dopamine (DA) ejection, indicated by back bar (E) 60 Hz, 24 p
electrical stimulation (ES), indicated with dashed vertical lines. The
horizontal boxes above each histogram indicate where comparisons
were made to determine prolonged changes in firing rate. Red
indicates baseline (−15 to 30 s in panel A) and blue outlined boxes
indicate regions compared to baseline (−15 to 0 s and 15 to 30 s). (F)
Summary graph of immediate and prolonged changes in firing ratio
from the single unit in panels (A)−(E). Prolonged firing ratios were
determined by dividing the average firing rate during periods with blue
boxes over them in a panel by the red boxed region in panel (A).
Immediate firing ratios were determined as described in Figure 5 and
the text. A quotient greater than 1.5 or less than 0.5 qualified as a
change in frequency of cell firing. Horizontal dashed lines enclose the
region where changes in firing ratio are less than 50% of the original
signal. The only effect seen at this cell was a prolonged depression to
SCH23390 as indicated by the asterisk (*) in panel (F).
Table 2. Medium Spiny Neuron Responses to Electrically
Stimulated Dopamine and Locally Applied Dopaminea
no. of cells (%)
type of prolonged response ES and DA DA onlyb ES onlyc
excitatory 12 (30) 5 (12) 3 (8)
inhibitory 14 (35) 0 (0) 0 (0)
no responsed 4 (10) − −
mixed responsee 2 (5) − −
aDA = locally applied dopamine; ES = electrically stimulated release.
MSN responses are tabulated from n = 40 cells (units) from 21 rats.
bCells responded to DA only and had no response to ES. cCells
responded to ES only and had no response to DA. dCells did not
respond to ES or DA. eCells with a mixed response responded
differently to ES vs DA. One of the cells had an inhibitory response to
ES and an excitatory response to DA, while the other cell had an
excitatory response to ES and an inhibitory response to DA.
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required at postsynaptic receptors to elicit comparable adenylyl
cylase inhibitions.
Our results provide an interpretable view of dopamine−
receptor interactions because of our ability to monitor the
applied drug concentration. In previous studies of dopamine’s
actions on MSNs, the dopamine concentration was not
monitored directly but based on barrel concentrations and
applied currents. The amount of dopamine applied in those
experiments can be estimated to be considerably greater than
the concentrations applied in this work.52 In studies where
dopamine was exclusively inhibitory, the large concentrations of
dopamine applied meant that uptake by the dopamine
transporter could not make a significant change in the applied
concentration.
Our initial iontophoresis experiments demonstrate at least
three unique pharmacological responses that indicate the
presence of different receptor populations on individual
MSNs (Table 1) and these results are consistent with the
current understanding of the distribution of D1 and D2
receptors in the NAc.25 This also supports the classic theory
that the effect of dopamine on MSN intrinsic and synaptic
channels will be excitatory at D1 MSNs and inhibitory at D2
MSNs.53−55 The prolonged effect of dopamine on MSN firing
was independent of the receptor subtypes in these animals that
were at rest.
We have presented a technique and methodology that is
uniquely designed to determine not only what dopamine does
in an awake animal under a number of conditions but that also
has the potential to tease apart the role of other neuro-
transmitters in conjunction with dopamine. Characterization of
this combined technique allows us to begin to differentiate
between the function of MSNs based on their receptors. We
can now investigate the argument that many different circuits
within the NAc fire in different patterns specific to the aspect of
goal-directed behavior for which they encode.56 These initial
data are very promising and show the potential of this
combined technique to contribute to a broader understanding
of neuronal signaling.
■ METHODS
Electrode Modifications. A capillary (Part # 624503, 0.60 mm
o.d., 0.4 mm i.d., 4′′ long, A-M Systems, Sequim, WA) was loaded with
a carbon fiber (T-650, Thornel, Amoco Corp., Greenville, SC) by
aspiration and then loaded into one barrel of a prefused four-barrel
glass (Part # 4FB100-75-100, 1.0 mm OD, 0.75 mm ID, 100 mm L,
four-barrel omega dot tubing with filament, Friedrich and Dimmock,
Millville, NJ). The four-barrel glass with attached heat shrink (to
prevent microfractures in the glass) was pulled on a vertical micropipet
puller (Narashige, Tokyo, Japan). When pulling, it is important that
the multibarrel glass capillary is completely centered and straight
within the coil of the puller. If the glass moved at all from the center of
the coil when the chuck was rotated, the probe moved the same way
when lowered into the brain. This greatly increased the likelihood of
chipping or breaking the probe on the guide cannula or otherwise
damaging the electrode seal.
In experiments described here, one iontophoresis barrel was filled
with 5 mM dopamine dissolved in 5 mM NaCl. The additional two
barrels were filled with either 5 mM of the D2-antagonist raclopride, 5
mM of the D1 antagonist SCH-23390, or 5 mM of the dopamine
uptake inhibitor nomifensine. All drugs were dissolved in 5 mM NaCl
containing 5 mM acetaminophen.18 Acetaminophen served as the
electroactive marker that allowed ejections to be monitored and
quantitated with FSCV the amount of electroinactive drug ejected was
calculated indirectly from relative electrophoretic mobilities with
respect to acetaminophen as done previously.17 Capillary electro-
phoresis and previously established methodology were used to
determine that the relative electrophoretic mobilities of raclopride
and SCH 23390 and nomifensine are 1.68, 1.90, and 2.24, respectively,
compared to acetaminophen. Positive current was used to eject all
drugs. The current was adjusted during “priming”18 to deliver the
appropriate micromolar concentration (detected with FSCV at the
carbon-fiber) of dopamine or acetaminophen during a 15 s ejection.
Between probes and from barrel to barrel, the amount of current
required to achieve a desired concentration varied from 10 to 450 nA.
During experiments, drug application was randomized.
After barrels were loaded with drug solutions, the probe was
inserted connection side first, into the modified Biela manipulator and
fastened to the manipulator with a strip of parafilm. A gold pin was
then soldered to the end of the silver wire connected to the carbon-
fiber electrode; separate silver wires were inserted into each preloaded
iontophoresis barrel, and all connections were secured to the probe
with parafilm. A final check occurred to ensure that the electrode tip
was centered and only moved straight up and down, not in circular
motions, with turning of the manipulator.
For the range of acetaminophen concentrations used in these
experiments, acetaminophen toxicity is considered unlikely. The first
step in acetaminophen metabolism is its oxidation by cytochrome
P450 2E1, which is predominately found in the liver.57 The enzyme is
present in the brain but in smaller amounts (0.5−2% of liver
concentration).58,59 This enzyme metabolizes acetaminophen into a
toxic, reactive intermediate that under normal conditions is
immediately broken down into a nontoxic compound by glutathione.
The reactive intermediate can cause damage if there is an
overexpression of the enzyme (normally due to chronic ethanol
treatment) or if the glutathione concentration is low.60 Here, however,
the plasma concentrations of acetaminophen were below 2 mM (the
level for hepatoxicity).61
Cannula and Manipulator Modifications. Biela manipulators
designed for four-barrel glass were obtained commercially (Crist
Instrument Co, Part# 3-MMB-3D). Before surgical implantation of the
guide cannula, the custom-made adapter was used to stretch the guide
cannula (Bioanalytical Systems, West Lafayette, IN) slightly to ensure
that the manipulator could easily slide into the cannula. Without this
step, insertion of the manipulator into the cannula took more force
which may stress the animal or electrode.
Combined Electrochemistry/Electrophysiology Instrumen-
tation. A version of the custom build headstage27 with pins to connect
the iontophoresis barrels to the current source was constructed by the
UNC Electronics Facility. An iontophoretic constant current delivery
system (NeuroPhore BH-2 System, Harvard Apparatus, Holliston,
MA) was used for all iontophoretic ejections. All electrical signals were
passed through an electrical swivel (Med-Associates, St. Albans, VT)
that allowed the animal unrestrained movement within the behavioral
chamber.8
Surgeries. For recovery surgeries, male Sprague−Dawley rats
(225−350 g; Charles River, Wilmington, MA) were anesthetized with
isofluorane (rats were induced at 4% and maintained at 1.5−2.0%
during surgery) and placed in a stereotaxic frame (Kopf, Tujunga,
CA). Surgeries were performed as previously described.36,62,63 The
stretched guide cannula was implanted with the hub extending 2.5 mm
into the brain directly above the NAc core (1.3 AP, 1.3 ML) or shell
(1.7 AP, 0.8 ML, N = 4 animals, and n = 8 cells),64 and a bipolar
stimulating electrode (Plastics One, Roanoke, VA) was lowered into
the VTA (5.2 mm AP, 1.0 mm ML, and 7.8 mm DV). Coordinates for
the bipolar stimulating electrode ensure activation of the neurons
projecting to the NAc.65 A Ag/AgCl electrode was placed in the
contralateral hemisphere to act as both reference for the carbon-fiber
electrode and a ground for the iontophoresis barrels. All items were
secured to the skull with stainless steel screws and dental cement. Rats
inhaled 100% oxygen for a few minutes at the end of the surgery and
were given tylenol (15 mg/kg) to aid in their recovery.
Experiments with anesthetized animals were similar except for
anesthesia used. Rats were anesthetized with 1.5 g/kg urethane (50%
urethane/50% saline, w/w). Identical coordinates were used for
implantation of electrodes. All procedures were approved by the
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Institutional Animal Care and Use Committee of the University of
North Carolina.
Data Acquisition. After at least a 3 day recovery period, rats were
anesthetized in an isofluorane chamber (4% for ∼2 min). Once lightly
anesthetized, rats were removed from the chamber and the implanted
cannula rinsed with 0.9% bacteriostatic saline (Animal Health
International, Greely, CO). Isofluorane anesthetization lasts only a
few minutes, and it has no measurable effect on an animal’s ability to
perform ICSS or on electrically stimulated [DA]max.
66,67 The loaded
manipulator was then attached to the cannula, and the rat was placed
into a behavioral chamber (Med Associates, St Albans, VT). Once in
the chamber, the electrode and iontophoresis connections were made
to the custom built headstage (Chemistry Department Electronics
Facility, University of North Carolina, Chapel Hill).
The probe was slowly lowered to 6.0 mm in the brain (1 turn of the
manipulator moved the electrode 0.4 mm). The electrode was then
cycled for 15 min at 60 Hz from −0.4 to 1.3 V and back at 400 V/s68
using custom-built software (Tarheel CV, LABVIEW, National
Instruments, Austin, TX), and then cycled for 10 min with the same
waveform applied at 10 Hz. The iontophoresis barrels were primed as
described previously,18 and pump currents to deliver the desired
amount of each drug were determined at a depth of 6.0 mm into the
brain. The electrode was then lowered into the NAc (7.0 mm DV),
and the waveform was altered to allow FSCV and electrophysiological
recordings.36 Figure 1 shows the circuitry that allowed this switching
to occur along with the simultaneous outputs from each circuit. A
solid-state relay in the headstage alternated between the current
amplifier for voltammetric scans and a voltage follower for unit
recording. This complementary metal−oxide−semiconductor
(CMOS) switch (MAX 319CSA) was chosen due to its low leakage,
low charge transfer, low and matched input capacitance, low resistance
(10 Ω), and fast (<1 μs) switching time.27 The unit-recording interval
had a 20 ms gap every 180 ms when voltammograms were collected.
In the first 5.75 ms of this interval, a potential of −0.4 V was applied.
The potential sweep for voltammetry remained the same as during the
initial cycling.
Once in the NAc, data collection occurred at sites where a single
unit was isolated. A single unit was classified as an MSN if baseline
firing frequency was below 15 Hz and the waveform duration was less
than 1.2 ms.69,70 After unit activity was monitored for 30 min to ensure
a constant firing rate, drug was applied to the unit. The probe
configuration allowed a maximum of three drugs applied per cell, so
separate experiments were carried out prior to reported experiments
where cell firing was monitored during ejections of 5 mM
acetaminophen in 5 mM NaCl in rats during and prior to ICSS.
Cell firing was not modulated by ejections of the neutral marker
acetaminophen (N = 4 rats, n = 6 cells). Drugs were applied in a
randomized order from cell to cell within an animal and from animal
to animal to ensure affects were not due to the drug sequence. Positive
currents were used for all ejections (10−450 nA). Multiple recording
locations were used in a single animal provided they were at least 300
μm apart to ensure a new MSN was being recorded. Units recorded at
carbon-fiber electrodes were amplified (×1000) and band-pass filtered
(300−3000 Hz). All signals were digitized with commercially available
software (DIGITIZER, Plexon, Dallas, TX), and isolation of a unit was
accomplished with principal component analysis in commercially
available software (OFFLINE SORTER, Plexon, Dallas, TX). Med-
Associates software (St. Albans, VT) controlled iontophoresis
ejections and provided digital outputs synchronized to behavioral
cues that were recorded in both Tarheel CV (fast-scan voltammetry)
and Plexon (electrophysiology) records.
Data Analysis. Dopamine was identified from the background
subtracted cyclic voltammograms.71 Current traces showed changes in
dopamine concentration over time at the oxidation potential of
dopamine from the cyclic voltammograms collected every 200 ms.
Neural activity was characterized with raster displays and peri-event
histograms (PEHs) across distinct time domains that bracketed the
iontophoretic ejections. Each PEH was partitioned into three parts
[baseline (15 s before the ejection), response (15 s during ejection),
and recovery (15 s after the ejection)] to allow measurement of
changes relative to the drug application. We use N to indicate number
of animals and n to equal the number units.
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